Vafseo Tablet, Film Coated
Product Images NDC 59922-643

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Vafseo (NDC 59922-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akebia Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vafseo Figure 01)

Chemical structure of Vadadustat, the active ingredient in VAFSEO tablets. The diagram shows the molecular formula with labeled atoms and bonds, including the presence of chlorine (Cl), hydroxyl (OH), and carboxylic acid (COOH) functional groups.*

FDA Label Image

Figure 1 (Vafseo Figure 02)

A scatter plot chart depicting the impact of various other drugs on the pharmacokinetics of Vadadustat, including inhibitors, pH modifiers, iron supplements, and phosphate binders. The x-axis shows the change relative to reference (without interaction) as geometric mean ratios with 90% confidence intervals for AUC and Cmax values, comparing drug interactions on Vadadustat pharmacokinetics.*

FDA Label Image

Figure 2 (Vafseo Figure 03)

A pharmacokinetic impact chart illustrating the effect of Vadadustat on the exposure (AUC) and peak concentration (Cmax) of various drugs grouped by substrate types including HMG Co-A Reductase Inhibitors (Statins), OAT1, CYP2C9, P-gp, OAT3, and BCRP substrates. It shows geometric mean ratio values with 90% confidence intervals relative to reference values without interaction.*

FDA Label Image

Carton Label (Vafseo Figure 04)

Packaging label for Vafseo (vadadustat) 150 mg tablets, film coated, oral solid dosage form. The carton contains 60 tablets and is manufactured for Akebia Therapeutics, Inc. The label includes storage instructions, dosage recommendations, and barcodes, with branding elements such as the Vafseo logo and Akebia Therapeutics logo.*

FDA Label Image

60 Count Bottle Label (Vafseo Figure 05)

Vafseo (vadadustat) 150 mg film-coated tablets label for a 60-tablet package. The label includes storage instructions, mentions the product is Rx only, and lists Akebia Therapeutics, Inc. as the manufacturer. It features a barcode, a QR code, and designated spaces for lot and expiration dates.*

FDA Label Image

Carton Label (Vafseo Figure 06)

Vafseo (vadadustat) 300 mg film-coated tablets packaging label showing the product name, strength, dosage form, and quantity of 60 tablets. The label includes storage instructions, warnings to swallow tablets whole, and manufacturer information indicating Akebia Therapeutics, Inc. The label also displays the NDC number 59922-642-60, barcodes, and the direction to dispense with the enclosed Medication Guide.*

FDA Label Image

60 Count Bottle Label (Vafseo Figure 07)

Vafseo (vadadustat) 300 mg oral film-coated tablets carton label showing quantity of 60 tablets. The label includes storage instructions and manufacturer information indicating it is made for Akebia Therapeutics, Inc., Cambridge, MA, and is a product of Spain. Dosage instructions advise swallowing tablets whole without cutting or crushing.*

FDA Label Image

Carton Label (Vafseo Figure 08)

Packaging label for Vafseo (vadadustat) oral film-coated tablets, 450 mg strength, in a 60-tablet package. The label displays the product name, dosage strength, labeler Akebia Therapeutics, Inc., and includes barcodes and NDC code 59922-643-60. The label also contains dosage recommendations and storage instructions.*

FDA Label Image

60 Count Bottle Label (Vafseo Figure 09)

Label for Vafseo (vadadustat) tablets, film coated, 450 mg strength. The label indicates a package of 60 tablets and includes storage instructions between 20°C to 25°C with permitted excursions from 15°C to 30°C. Manufactured for Akebia Therapeutics, Inc., Cambridge, MA, product of Spain. Contains a barcode, NDC 59922-643-60, and a note to dispense with the enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.